Digest Network Come funziona
Network
/
Società
4M
Non verificato

4M Therapeutics Inc.

Di cosa scriviamo

BiotecnologiaMedicina - VarieSaluteSanitàScienza

6 comunicati stampa

Guarda tutti i comunicati
25/09/2025
Mercato del lavoro
Salute
Scienza
Sanità
Biotecnologia
4M Therapeutics Announces Appointment of Industry Veteran Edward Scolnick, M.D., as Senior Scientific Advisor
Fonte
4M Therapeutics Inc.
Emittente
Business Wire
1.00
0
11/06/2025
Salute
Medicina - Varie
Sanità
Scienza
Cardiologia
Industria
4M Therapeutics Reports Positive Results from 4MT2001 GLP Safety Studies
Fonte
4M Therapeutics Inc.
Emittente
Business Wire
1.00
0
21/04/2025
Eventi
Industria
Salute
Sanità
Farmaceutica
Biotecnologia
4M Therapeutics to Present at the Upcoming American Psychological Association and American Society of Clinical Psychopharmacology Annual Meetings
Fonte
4M Therapeutics Inc.
Emittente
Business Wire
1.00
0
12/11/2024
Salute
Sanità
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
4M Therapeutics Awarded $120,000 Grant from SynGAP Research Fund to Evaluate GSK3β Inhibition in Preclinical SYNGAP1-Related Disorders Research
Fonte
4M Therapeutics Inc.
Emittente
Business Wire
1.00
0
17/10/2024
Industria
Scienza
Psichiatria
Biotecnologia
Medicina - Varie
Sanità
Farmaceutica
Salute
4M Therapeutics’ Compounds to Be Utilized in Research Project Funded by National Institute on Aging
Fonte
4M Therapeutics Inc.
Emittente
Business Wire
1.00
0
09/09/2024
Eventi
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Psichiatria
Medicina - Varie
4M Therapeutics Announces Positive Preclinical Data for Lead Asset 4MT2001 Demonstrating Central Nervous System Target Engagement
Fonte
4M Therapeutics Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0